Cost utility of fractional flow reserve-guided percutaneous coronary intervention in multivessel coronary artery disease in Brazil.
Stella, Steffan Frosi; Polanczyk, Carísi Anne; Arvandi, Marjan; Siebert, Uwe.
Int J Qual Health Care
; 2018 Dec 20.
Artigo em Inglês | MEDLINE | ID: mdl-30576452
Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease.
Cost-effectiveness of intraoperative nerve monitoring in avoidance of bilateral recurrent laryngeal nerve injury in patients undergoing total thyroidectomy.
Cost utility modeling of early vs late total knee replacement in osteoarthritis patients.
Cost-utility of a six-month programmed sports therapy (PST) in patients with haemophilia.
What is known about the cost-effectiveness of orphan drugs? Evidence from cost-utility analyses.
Much cheaper, almost as good: decrementally cost-effective medical innovation.
The Cost-Effectiveness of Using Platelet-Rich Plasma During Rotator Cuff Repair: A Markov Model Analysis.
Negative pressure wound therapy for open traumatic wounds.
Cost-effectiveness of percutaneous coronary intervention in patients with stable coronary artery disease and abnormal fractional flow reserve.
A cost-utility analysis of dabigatran, enoxaparin, and usual care for venous thromboprophylaxis after hip or knee replacement surgery in Thailand.